Glaxosmithkline Plc Adr Stock Price History

GSK Stock  USD 40.86  0.38  0.92%   
Below is the normalized historical share price chart for GlaxoSmithKline PLC ADR extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of GlaxoSmithKline PLC stands at 40.86, as last reported on the 25th of April, with the highest price reaching 41.24 and the lowest price hitting 40.64 during the day.
IPO Date
9th of July 1986
200 Day MA
37.84
50 Day MA
41.8334
Beta
0.268
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in GlaxoSmithKline Stock, it is important to understand the factors that can impact its price. We consider GlaxoSmithKline PLC very steady. GlaxoSmithKline PLC ADR holds Efficiency (Sharpe) Ratio of 0.0926, which attests that the entity had a 0.0926% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for GlaxoSmithKline PLC ADR, which you can use to evaluate the volatility of the firm. Please check out GlaxoSmithKline PLC's market risk adjusted performance of 0.1261, and Risk Adjusted Performance of 0.0531 to validate if the risk estimate we provide is consistent with the expected return of 0.093%.
  
At this time, GlaxoSmithKline PLC's Total Stockholder Equity is quite stable compared to the past year. Common Stock Total Equity is expected to rise to about 1.6 B this year, although the value of Other Stockholder Equity will most likely fall to about 2.9 B. . At this time, GlaxoSmithKline PLC's Price Fair Value is quite stable compared to the past year. GlaxoSmithKline Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0926

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashGSKAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.0
  actual daily
8
92% of assets are more volatile

Expected Return

 0.09
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
7
93% of assets perform better
Based on monthly moving average GlaxoSmithKline PLC is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GlaxoSmithKline PLC by adding it to a well-diversified portfolio.
Price Book
4.9647
Enterprise Value Ebitda
11.0822
Price Sales
2.7514
Shares Float
3.9 B
Dividend Share
0.58

GlaxoSmithKline PLC Stock Price History Chart

There are several ways to analyze GlaxoSmithKline Stock price data. The simplest method is using a basic GlaxoSmithKline candlestick price chart, which shows GlaxoSmithKline PLC price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 7, 202443.58
Lowest PriceJanuary 29, 202438.68

GlaxoSmithKline PLC April 25, 2024 Stock Price Synopsis

Various analyses of GlaxoSmithKline PLC's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell GlaxoSmithKline Stock. It can be used to describe the percentage change in the price of GlaxoSmithKline PLC from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of GlaxoSmithKline Stock.
GlaxoSmithKline PLC Price Action Indicator(0.27)
GlaxoSmithKline PLC Accumulation Distribution 26,423 
GlaxoSmithKline PLC Price Daily Balance Of Power(0.63)
GlaxoSmithKline PLC Price Rate Of Daily Change 0.99 

GlaxoSmithKline PLC April 25, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in GlaxoSmithKline Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use GlaxoSmithKline PLC intraday prices and daily technical indicators to check the level of noise trading in GlaxoSmithKline Stock and then apply it to test your longer-term investment strategies against GlaxoSmithKline.

GlaxoSmithKline Stock Price History Data

The price series of GlaxoSmithKline PLC for the period between Fri, Jan 26, 2024 and Thu, Apr 25, 2024 has a statistical range of 5.12 with a coefficient of variation of 3.31. Under current investment horizon, the daily prices are spread out with arithmetic mean of 41.3. The median price for the last 90 days is 41.53. The company completed 1226:1000 stock split on 22nd of July 2022. GlaxoSmithKline PLC ADR completed dividends distribution on 2024-02-22.
OpenHighLowCloseVolume
04/24/2024 41.20  41.24  40.64  40.86  1,816,111 
04/23/2024 40.66  41.26  40.60  41.24  2,289,891 
04/22/2024 39.99  40.76  39.96  40.59  3,800,880 
04/19/2024 39.37  39.76  39.37  39.75  1,623,860 
04/18/2024 39.39  39.50  39.16  39.27  2,636,937 
04/17/2024 39.72  39.85  39.44  39.60  3,208,339 
04/16/2024 40.02  40.23  39.72  39.95  2,422,694 
04/15/2024 40.90  41.06  40.44  40.50  3,373,749 
04/12/2024 40.96  40.97  40.49  40.66  5,264,694 
04/11/2024 41.00  41.25  40.68  40.80  2,903,779 
04/10/2024 40.62  40.75  40.49  40.69  4,370,362 
04/09/2024 40.89  40.96  40.67  40.88  3,191,316 
04/08/2024 41.08  41.08  40.82  40.85  1,856,122 
04/05/2024 40.59  41.25  40.53  41.19  6,093,091 
04/04/2024 41.73  41.88  40.84  40.86  2,634,110 
04/03/2024 41.50  41.74  41.33  41.54  3,048,509 
04/02/2024 42.13  42.14  41.67  41.79  2,581,946 
04/01/2024 42.74  42.87  42.23  42.42  1,514,946 
03/28/2024 43.00  43.22  42.86  42.87  1,854,672 
03/27/2024 42.58  43.03  42.51  42.99  2,076,567 
03/26/2024 42.83  42.89  42.55  42.79  3,041,365 
03/25/2024 42.58  43.45  42.56  42.83  3,436,973 
03/22/2024 42.54  42.68  42.33  42.35  1,482,675 
03/21/2024 42.17  42.54  42.15  42.37  2,024,457 
03/20/2024 42.02  42.04  41.75  41.93  1,799,289 
03/19/2024 42.24  42.33  42.07  42.32  1,998,797 
03/18/2024 42.21  42.35  42.14  42.14  1,346,141 
03/15/2024 42.28  42.43  41.81  42.19  4,130,049 
03/14/2024 43.21  43.26  42.81  43.08  1,843,304 
03/13/2024 43.27  43.37  43.08  43.36  1,677,763 
03/12/2024 42.93  43.27  42.81  43.27  2,196,713 
03/11/2024 42.88  42.96  42.73  42.92  2,514,787 
03/08/2024 43.02  43.22  42.91  43.14  3,308,066 
03/07/2024 43.68  43.84  43.48  43.58  4,382,276 
03/06/2024 42.38  42.71  42.33  42.62  3,045,804 
03/05/2024 42.63  42.78  42.49  42.60  2,635,233 
03/04/2024 42.04  42.44  42.02  42.44  2,404,302 
03/01/2024 42.01  42.09  41.78  42.03  2,324,666 
02/29/2024 42.65  42.69  41.80  41.90  4,381,394 
02/28/2024 42.35  42.44  42.13  42.34  4,040,209 
02/27/2024 42.12  42.44  42.07  42.38  3,733,637 
02/26/2024 42.52  42.59  42.25  42.34  3,022,721 
02/23/2024 42.35  42.45  42.14  42.22  3,440,906 
02/22/2024 41.65  42.24  41.63  42.16  6,179,372 
02/21/2024 41.82  41.99  41.53  41.53  3,661,177 
02/20/2024 42.26  42.61  41.61  41.61  4,154,312 
02/16/2024 42.00  42.23  41.53  41.53  3,765,798 
02/15/2024 41.78  42.02  41.37  41.37  4,144,993 
02/14/2024 41.76  41.93  41.40  41.40  7,442,574 
02/13/2024 41.57  41.60  40.99  40.99  7,056,902 
02/12/2024 41.41  41.41  40.67  40.67  6,688,824 
02/09/2024 41.96  42.06  41.50  41.50  3,503,429 
02/08/2024 41.82  41.89  41.42  41.42  4,303,324 
02/07/2024 41.93  42.21  41.61  41.61  6,042,880 
02/06/2024 41.69  41.77  41.30  41.35  3,671,690 
02/05/2024 41.77  41.89  41.17  41.17  7,985,062 
02/02/2024 40.61  40.85  40.33  40.33  3,925,361 
02/01/2024 39.94  40.69  39.85  40.24  5,355,049 
01/31/2024 40.67  41.31  39.06  39.06  7,553,305 
01/30/2024 39.16  39.21  38.71  38.71  2,393,933 
01/29/2024 39.19  39.21  38.68  38.68  2,178,606 

About GlaxoSmithKline PLC Stock history

GlaxoSmithKline PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GlaxoSmithKline is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GlaxoSmithKline PLC ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GlaxoSmithKline PLC stock prices may prove useful in developing a viable investing in GlaxoSmithKline PLC
Last ReportedProjected for Next Year
Common Stock Shares Outstanding4.1 B2.2 B
Net Income Applicable To Common Shares13.5 B14.1 B

GlaxoSmithKline PLC Stock Technical Analysis

GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of GlaxoSmithKline PLC technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of GlaxoSmithKline PLC trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

GlaxoSmithKline PLC Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for GlaxoSmithKline PLC's price direction in advance. Along with the technical and fundamental analysis of GlaxoSmithKline Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GlaxoSmithKline to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
0.58
Earnings Share
2.97
Revenue Per Share
14.97
Quarterly Revenue Growth
0.092
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.